Ultrasound-enhanced delivery of polymer-coated oncolytic adenovirus for tumour growth inhibition

Ultrasound-enhanced delivery of polymer-coated oncolytic adenovirus for tumour growth inhibition

Opis bibliograficzny
Główni autorzy:	Carlisle, R, Choi, J, Kostka, L, Bazan-Peregrino, M, Ulbrich, K, Coussios, C, Seymour, L
Format:	Journal article
Wydane:	2011

Podobne zapisy

Cavitation-enhanced delivery of a replicating oncolytic adenovirus to tumors using focused ultrasound.
od: Bazan-Peregrino, M, i wsp.
Wydane: (2013)

Cavitation-enhanced delivery of a self-amplifying oncolytic adenovirus for tumour-selective cancer therapy.
od: Carlisle, R, i wsp.
Wydane: (2012)

Ultrasound-induced cavitation enhances the delivery and therapeutic efficacy of an oncolytic virus in an in vitro model
od: Bazan-Peregrino, M, i wsp.
Wydane: (2012)

Ultrasound-induced cavitation enhances the delivery and therapeutic efficacy of an oncolytic virus in an in vitro model.
od: Bazan-Peregrino, M, i wsp.
Wydane: (2012)

Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasound.
od: Carlisle, R, i wsp.
Wydane: (2013)

Factors influencing retention of adenovirus within tumours following direct intratumoural injection.
od: Bazan-Peregrino, M, i wsp.
Wydane: (2008)

Coating of adenovirus type 5 with polymers containing quaternary amines prevents binding to blood components.
od: Subr, V, i wsp.
Wydane: (2009)

Passive tumour targeting of polymer-coated adenovirus for cancer gene therapy.
od: Fisher, K, i wsp.
Wydane: (2007)

Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus.
od: Bazan-Peregrino, M, i wsp.
Wydane: (2008)

Increasing the density of nanomedicines improves their ultrasound-mediated delivery to tumours
od: Mo, S, i wsp.
Wydane: (2015)

Increased Adenovirus density for increased ultrasound-mediated delivery to tumors
od: Carlisle, R, i wsp.
Wydane: (2013)

Polymer coatings for delivery of nucleic acid therapeutics.
od: Laga, R, i wsp.
Wydane: (2012)

Polymer coatings for delivery of nucleic acid therapeutics
od: Laga, R, i wsp.
Wydane: (2012)

Coating of adenovirus type 5 with cleavable PEGylated gold nanoparticles for enhanced protection and circulation
od: Mo, S, i wsp.
Wydane: (2013)

Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancer.
od: Green, N, i wsp.
Wydane: (2012)

Targeting adenovirus gene delivery to activated tumour-associated vasculature via endothelial selectins.
od: Bachtarzi, H, i wsp.
Wydane: (2011)

Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies
od: Fisher, K, i wsp.
Wydane: (2001)

Ultrasound-enhanced drug delivery for cancer.
od: Mo, S, i wsp.
Wydane: (2012)

Targeting polymer coated adenovirus to tumour-associated vasculature
od: Bachtarzi, H
Wydane: (2010)

Polymer stealthing and mucin-1 retargeting for enhanced pharmacokinetics of an oncolytic vaccinia virus
od: Hill, C, i wsp.
Wydane: (2021)

Use of synthetic vectors for neutralising antibody resistant delivery of replicating adenovirus DNA.
od: Carlisle, R, i wsp.
Wydane: (2006)

Factors responsible for inhibition of adenovirus infection by cellular debris and tumour lysate
od: Tedcastle, A, i wsp.
Wydane: (2011)

Cavitation-enhanced extravasation for drug delivery.
od: Arvanitis, C, i wsp.
Wydane: (2011)

Cavitation-Enhanced Extravasation for Drug Delivery
od: Arvanitis, C, i wsp.
Wydane: (2011)

The effect of polymer coating and different adenovirus serotypes on the innate immune responses to intraperitoneal adenovirus
od: Thoma, C, i wsp.
Wydane: (2008)

Achieving systemic delivery of oncolytic viruses
od: Hill, C, i wsp.
Wydane: (2019)

Polymer-coated polyplexes designed for triggered activation utilising intracellular reduction
od: Briggs, S, i wsp.
Wydane: (2004)

Polymer-coated polyethylenimine/DNA complexes designed for triggered activation by intracellular reduction.
od: Carlisle, R, i wsp.
Wydane: (2004)

Characterisation of a novel group B oncolytic adenovirus, ColoAd1
od: Di, Y, i wsp.
Wydane: (2011)

Combining oncolytic adenovirus with radiation – a paradigm for the future of radiosensitization
od: O'Cathail, S, i wsp.
Wydane: (2017)

Adenovirus type 5 interactions with human blood cells may compromise systemic delivery.
od: Lyons, M, i wsp.
Wydane: (2006)

Bioprocessing of oncolytic group B adenovirus for scalable production
od: Cooper, L
Wydane: (2014)

Use of micro- and nano-sized inertial cavitation nuclei to trigger and map drug release from cavitation-sensitive liposomes.
od: Graham, S, i wsp.
Wydane: (2013)

Evaluation of drug delivery vehicles for improved transduction of oncolytic adenoviruses in solid tumor tissue
od: Erik Yngve, i wsp.
Wydane: (2025-01-01)

Oncolytic adenoviruses and immunopeptidomics: a convenient marriage
od: Marc Garcia‐Moure, i wsp.
Wydane: (2024-04-01)

Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies
od: Freedman, J, i wsp.
Wydane: (2017)

Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy
od: Mahasa, K, i wsp.
Wydane: (2020)

Polymeric cups for cavitation mediated delivery of oncolytic vaccinia virus
od: Myers, R, i wsp.
Wydane: (2016)

Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer.
od: Green, N, i wsp.
Wydane: (2008)

Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor.
od: Morrison, J, i wsp.
Wydane: (2008)